About Westchester Medical Center   |   Contact Us   |   Press Room   |   Careers
For physician information, call (877) 962-3627

Press Releases

WMC Press Releases
WMC Ophthalmologist Using Tiny Telescope To Treat End-Stage Macular Degeneration

CONTACT:  David Billig        (914) 493 8028


Westchester Medical Center Ophthalmologist using tiny telescope to treat end-stage macular degeneration

 FDA approved telescope implant by Centrasight is the first-of-its-kind for treating patients with end-stage age-related macular degeneration (AMD)

Westchester Medical Center (WMC) Ophthalmologist, Dr. Gerald Zaidman has recently begun implanting the first-of-its-kind CentraSight implantable telescope for patients with end stage age related macular degeneration (AMD).  The FDA approved telescope implant is believed to be the only surgical option that improves vision by reducing the impact of the central vision blind spot caused by AMD. 

Patients who suffer from AMD, which is the leading cause of blindness in older Americans, have a central blind spot within their field of vision causing great difficulty in seeing when looking forward.   As a result of the condition, which worsens over many years, patients are left unable to recognize faces, read, watch TV, drive or perform many other daily tasks. 

The new telescopic implant, which is slightly smaller than a pea, uses micro-optical technology to magnify images that can be seen by their central, or straight ahead vision. The images are projected onto the healthy portion of the retina not affected by the disease.

“We are living longer, more active lives and as we age, continued quality of life is everything,” said Dr. Gerald Zaidman, Director of the Department of Ophthalmology at WMC.  “Up until now people who suffered from AMD and who gradually lost most of their vision also lost a lot of their quality of life. Although the procedure is not for everyone, the device may offer a new hope and improved quality of life for some patients who have suffered with continually worsening vision as a result of end-stage macular degeneration.” 

The telescope implant has been demonstrated in clinical trials to improve quality of life by improving patients’ vision so they can see the things that are important to them, increase their independence, and re-engage in everyday activities. It also may help patients in social settings, as it may allow them to recognize faces and see the facial expressions of family and friends.

Unfortunately, not everyone is eligible for the implant.  “There are specific requirements,” added Zaidman. Including: Patients must be at least 75-years old and meet certain vision health requirements. They must have End-Stage AMD resulting from either dry or wet AMD in both eyes and no longer be a candidate for drug treatment.  “In addition patients cannot have had cataract surgery in the eye where the telescope will be implanted and they must have adequate peripheral vision in the eye not scheduled for surgery.”

Westchester Medical Center is the only Center in the Hudson Valley and upstate NY and one of only a few in the Northeast that are fully prepped and performing the procedure. The Telescope implant is Medicare eligible.

About Westchester Medical Center

Spanning every adult and pediatric medical specialty, Westchester Medical Center serves as a lifeline to the more than 3.5 million people in the Hudson Valley region and beyond.  Well-known for its advanced medical care in trauma and burn, heart, cancer, transplant, neuroscience and pediatrics, community hospitals within a 5,000-square-mile range send their most difficult cases to this advanced-care, academic medical center.  With more than 900 attending physicians and 3,300 healthcare professionals, Westchester Medical Center is the only facility capable of providing immediate lifesaving advanced care between New York City and Albany. For more information on Westchester Medical Center visit: www.westchestermedicalcenter.com

About CentraSight

CentraSight is the a first-of-its-kind treatment program that utilizes a tiny telescope implant for end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.  Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight treatment program allows patients to see details again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with vision specialists to help the patient learn how to use their new vision for everyday activities. For more information visit: www.CentraSight.com.


Bookmark and Share
Decrease (-) Restore Default Increase (+)  

Archived records

2012 Press Releases
2011 Press Releases
2010 Press Releases
2009 Press Releases
2008 Press Releases

Connect with us:
Careers   |   Disclaimer   |   Privacy Practices   |   Site Map
Copyright © 2017 Westchester Medical Center | 100 Woods Road Valhalla, New York 10595 | (914) 493-7000